Update: Senate Pharma Grants Probe

As of late August, the Senate Committee on Finance had finished collecting an initial set of responses from pharmaceutical companies concerning educational grants but had not yet begun reviewing the responses; nor did it have a set timeline for finishing the review process. After going over the materials, the Committee will decide whether it will ask pharmaceutical companies for more detailed information and/or hold a hearing on the issue.

As we reported in the July/August issue, in J

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Already a member? .

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish